Is Ozempic fueling a new era of body image pressure? Join The Independent Debate - THE INDEPENDENT DEBATE: As weight-loss ...

The Washington Post covers efforts by insurers to clamp down on doctors prescribing Ozempic, now popular as a weight loss drug, for patients who don't evidently present with diabetes. Separately, CBS ...

What is it? A medication called semaglutide, which is sold under different brand names, including Ozempic, approved in 2017 for treating type 2 diabetes, and Wegovy, approved just last year for ...

Hers is a relatively new telehealth platform that offers prescription medications and customized support for weight loss. The ...

LOS ANGELES — It's 10 a.m. on a Friday at SURFCORE Fitness, a boutique gym in Mid-City, and a 52-year-old woman is following an exercise circuit as her trainer watches on. The fashion consultant ...

An FDA deadline instructing compounding pharmacies and telehealth companies to stop selling compounded versions of Ozempic and Zepbound has not stopped the copycat market, The Wall Street Journal ...

“Let’s address the elephant in the comments section. I am not on Ozempic. I am not sick. I didn’t get a face transplant and I didn’t get a brow lift,” Burke, 41, said in a video shared ...

Semaglutide, sold under brand names like Ozempic, Rybelsus, and Wegovy, belongs to a class of medications called GLP-1 receptor agonists. While FDA-approved for managing diabetes and aiding weight ...

Lars Fruergaard Jørgensen, president and CEO of Novo Nordisk, testifies during a Senate Health, Education, Labor and Pensions hearing to examine Novo Nordisk’s high prices for Ozempic and Wegovy for ...

Ozempic and Wegovy maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen on Friday over concerns the company is losing its first-mover advantage in the highly competitive obesity drug market.

(Reuters) -Ozempic-maker Novo Nordisk on Friday ousted its CEO Lars Fruergaard Jorgensen over concerns the company is losing its first-mover advantage in the competitive obesity drug market to ...

Sharon Osbourne, who has lost 42 pounds, began taking Ozempic in 2022 and opened up about her use of the drug publicly in 2023. In a November 2023 interview with the Daily Mail, Osbourne revealed, ...